SABBY MANAGEMENT, LLC - PHIO PHARMACEUTICALS CORP ownership

Back to all holdings Add to watchlist

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 19 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2021$83,000
-29.1%
40,684
-21.4%
0.01%
-31.2%
Q2 2021$117,000
+88.7%
51,756
+125.0%
0.02%
+33.3%
Q1 2021$62,000
-86.3%
23,007
-91.0%
0.01%
-93.6%
Q1 2020$452,000–255,194–0.19%–
 Download
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
VANGUARD GROUP INC 154,536$57,4870.00%
UBS Group AG 23,029$8,5210.00%
TWO SIGMA INVESTMENTS, LP 22,398$8,3320.00%
Cetera Investment Advisers 75,000$27,9000.00%
WELLS FARGO & COMPANY/MN 93$350.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 106,917$390.00%
MORGAN STANLEY 1,500$5580.00%
BlackRock Inc. 19$70.00%
TWO SIGMA SECURITIES, LLC 19,707$7,3310.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders